Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
[Delayed] Notice Regarding Personnel Changes in Directors and Corporate Officers
[Delayed] Notice Regarding Changes in Representative Directors and Corporate Officers at a Subsidiary
Consolidated Financial Results for the Nine months Ended December 31, 2025 (Under IFRS)
SAWAI GROUP, Apr-Dec (Cumulative 3Q) Net Income Decreases by 58%, Oct-Dec Net Income Decreases by 25%
Consolidated Financial Results for the six months Ended September 30, 2025 (Under IFRS)
SAWAI GROUP, First Half Net Income Decreases by 69%, Jul-Sep Net Income Decreases by 72%
SAWAI GROUP, Net Income Forecast for the Fiscal Year Revised Downward by 20%
Notice Regarding Recognition of Other Expenses (Provision for Loss on Litigation)
Notice Regarding Revisions to Forecasts of Financial Results
Notice Regarding Settlement of Lawsuit
Sawai Pharmaceutical and Nichi-Iko Agree on Cooperation for Item Integration of Generic Drugs, etc.
SAWAI GROUP, Apr-Jun (1Q) Net Income Decreases by 68%
Consolidated Financial Results for the three months Ended June 30, 2025 (Under IFRS)
Notice Regarding the Expansion of Production Capacity at Trust Pharmatech's Seima Plants -Group to Manufacture 25 billionTablets by Fiscal Year 2030-
Corporate Governance Report (Revised Version)
Notice Regarding the Completion of Payment for New Shares as Restricted Share Compensation
Sawai Completes the Acquisition of Shares of FrontAct Co., Ltd. to Make It a Subsidiary
Corporate Governance Report
ARTICLES OF INCORPORATION
Notice Regarding the Issuance of New Shares as Restricted Share Compensation